Newsroom

Statement, May 2016

South Centre Statement to the Open-Ended Meeting of WHO Member States: Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG)

At the open-ended meeting of WHO Member States on the follow-up of the report of the CEWG, the South Centre called for concrete discussions to start negotiations on a binding legal instrument on R&D financing and coordination. (more…)

Statement, 23 February 2016

World Economic Situation: Serious Difficulties Call For Bold Measures

Dr. Yılmaz Akyüz, Chief Economist of the intergovernmental organization South Centre, says that the 2008 financial crisis may be moving in a third wave that could devastate the Global South. (more…)

Statement, 17 March 2016

South Centre intervention to the UPOV Consultative Committee on the issue of interrelations with the FAO ITPGRFA

The South Centre participates as an observer in the ongoing process for the “identification of possible areas of interrelations between the FAO ITPGRFA, especially its Article 9 on Farmers’ Rights, and relevant instruments of UPOV and WIPO.” It seeks to promote an outcome that (more…)

Press release, 22 February 2016

The South Centre wishes to express its deepest condolences to the government and the people of Egypt for the passing away of Dr. Boutros Boutros-Ghali recently.

Mr. Boutros-Ghali was a giant in his support of multilateralism and an outstanding figure in promoting a more equitable world where peace should reign over war, and where the United Nations acts as an (more…)

Statement, 6 October 2015

South Centre at the WIPO 2015 Assemblies

The South Centre calls on WIPO Member States to guide the work of the organization towards shaping a more inclusive and balanced international intellectual property system.

(more…)

Statement, 6 October 2015

South Centre Calls on the WTO TRIPS Council to Support Access to Medicines and Technological Advancement for the Least Developed Countries

The South Centre fully supports the Least Developed Countries’ (LDC) request for an extension of the transition period granted to LDCs under Article 66.1 of the World Trade Organization’s Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) in respect of pharmaceutical products for as long as a WTO member remains an LDC, and the waiver from obligations under Articles 70.8 and 70.9 of the TRIPS Agreement. (more…)